Shopping Cart
- Remove All
Your shopping cart is currently empty
JMV3002 is a potent ghrelin receptor antagonist with an IC50 value of 1.1 nM in vitro. At 80 μg/kg, JMV3002 inhibits hexarelin-stimulated food intake by up to 98% in rats. It does not induce growth hormone release nor inhibit hexarelin-stimulated growth hormone secretion at a dose of 160 μg/kg in infant rats.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μg | $217 | 35 days | |
| 500 μg | $939 | 35 days | |
| 1 mg | $1,650 | 35 days | |
| 5 mg | $6,880 | 35 days |
| Description | JMV3002 is a potent ghrelin receptor antagonist with an IC50 value of 1.1 nM in vitro. At 80 μg/kg, JMV3002 inhibits hexarelin-stimulated food intake by up to 98% in rats. It does not induce growth hormone release nor inhibit hexarelin-stimulated growth hormone secretion at a dose of 160 μg/kg in infant rats. |
| Synonyms | JMV3002 |
| Molecular Weight | 586.68 |
| Formula | C35H34N6O3 |
| Cas No. | 925239-03-8 |
| Relative Density. | 1.25 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL (0.43 mM), Sonication is recommended. DMSO: 20 mg/mL (34.09 mM), Sonication is recommended. DMF: 30 mg/mL (51.14 mM), Sonication is recommended. Ethanol: 30 mg/mL (51.14 mM), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.